Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - graft+versus+host+disease
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Cell Based Immunotherapy
The invention hereby offered for licensing is in the field of Immunotherapy and more specifically in therapy of autoimmune diseases such as Type I diabetes, multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosis and immune mediated allergies such as asthma as well as in transplantation-related disorders, such as graft acceptance...
Published: 10/28/2024
|
Inventor(s):
Ethan Shevach
,
Dat Tran
Keywords(s):
2
,
ACTIVATED
,
ALLOWS
,
Aplastic anemia
,
Aplastic anemia, idiopathic; Aplastic anemia
,
Associated
,
CD121b
,
CELL-BASED
,
Cells
,
CULTURES
,
EXPANSION
,
Expression
,
FOXP3+
,
Generate
,
Graft versus host disease
,
Human
,
IB3XXX
,
IBXXXX
,
Idiopathic thrombocytopenic purpura
,
IL-l
,
Immunotherapy
,
IXXXXX
,
LAP
,
Latency
,
NUMBERS
,
Patent Category - Biotechnology
,
Peptide
,
purification
,
RECEPTOR
,
Regulatory
,
SELECTIVE
,
Sufficient
,
Systemic lupus erythematosus
,
T
,
Their
,
Thrombocytopenic purpura, autoimmune
,
TYPE
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
Application > Therapeutics
,
TherapeuticArea > Immunology
,
Application > Diagnostics
,
Application > Research Materials
Methods of Inducing Immune Tolerance Using Immunotoxins
The invention concerns immunotoxins and methods of using the immunotoxins for the treatment of rejection response in a patient, including graft-versus-host disease and transplantation of organs, tissues and cells into a host. In a specific embodiment of the invention, the transplant involves pancreatic islet cells. The immunotoxins are targeted via...
Published: 10/28/2024
|
Inventor(s):
David Neville
Keywords(s):
Activity
,
Agents
,
CB1XXX
,
CBXXXX
,
Cell
,
COMBINED
,
CXXXXX
,
Dendritic
,
Graft versus host disease
,
IB3XXX
,
IBXXXX
,
IMMUNE
,
Immunotoxin
,
IMMUNOTOXINS
,
Induce
,
INDUCING
,
INHIBIT
,
IN-VIVO
,
ISLET
,
IXXXXX
,
Maturation
,
Methds
,
Method
,
Methods
,
Novel
,
Pancreatic
,
RELATED
,
SUPPRESSANT
,
T
,
That
,
TOLERANCE
,
TRANSPLANTATION
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Immunology
,
Application > Research Materials
,
Application > Diagnostics
,
TherapeuticArea > Oncology
,
Application > Therapeutics
Methods for Expression and Purification of Immunotoxins
The invention concerns immunotoxins and methods of making the immunotoxins. Targeting of the immunotoxins occurs via an antibody that is specific to T cells. This allows the specific ablation of malignant T cells and resting T cells. The transient ablation of resting T cells can "reset" the immune system by accentuating tolerizing responses. As...
Published: 10/28/2024
|
Inventor(s):
David Neville
Keywords(s):
Aplastic anemia
,
Are
,
Bivalent
,
CB6XXX
,
CBXXXX
,
COMPLEX
,
CXXXXX
,
ESSENTIAL
,
Graft versus host disease
,
IB3XXX
,
IBXXXX
,
Immunotoxin
,
IXXXXX
,
LOW
,
lymphoma
,
Media
,
PASTORIS
,
PICHIA
,
production
,
temperature
Category(s):
Collaboration Sought > Licensing
,
Application > Research Materials
,
TherapeuticArea > Immunology
,
Application > Diagnostics
,
Application > Therapeutics
,
TherapeuticArea > Oncology